Heritage Global Partners is selling late model laboratory assets from Nektar Therapeutics. Nektar Therapeutics is a global biopharmaceutical company based in San Francisco. The firm develops novel therapies for the treatment of autoimmune disorders, cancer and chronic inflammatory conditions.
The online auction opens on the 29th of June and bidding ends on the 30th of June. Equipment available in the sale includes: Thermo Q Exactive Plus mass spectrometer with Waters Acquity UPLC system, Bruker Maldi TOF/TOF mass spectrometer, Thermo Orbitrap Fusion Lumos ETD mass spectrometer with Waters Acquity UPLC system, (10) GE AKTA Avant 25 and 150 chromatography system, (2) BD LSRFortessa X-20 flow cytometer, (8) Waters Acquity UPLC systems, Agilent Stratagene Mx3005P real time PCR system, (8) Agilent 1290 HPLC systems, (3) Molecular Devices SpectraMax i3X, (5) Waters HPLC systems, Unchained Labs Lunatic UV/Vis absorbance spectrometer, Unchained Labs Stunner automatic protein analyzer, Beckman Coulter CESI 8000 Plus high performance separation system, (2) Protein Simple MauriceCapillary electrophorosis system, Beckman Coulter ViCell BLU, Unchained Labs Uncle automatic protein analyzer, Applied Biosystems QuantStudio 7 Flex and more.
Heritage Global Partners is a California-based auctioneering firm offering a full range of services, from single asset sales through to turnkey facilities and complete factories. Heritage Global Partners has a global presence, operating in 30 countries worldwide. Conducting 150-200 auctions every year, the firm works with clients in over 25 sectors including the pharmaceutical, food and beverage, aerospace and biotech industries.
For further information about this, or any other Heritage Global Partners auction, please visit:
